Sidelined during the Covid-19 pandemic, the country’s deadliest disease has been working under cover
Less than half of those treated for resistant strains of TB survive. It’s just not good enough.
New drugs are working on XDR-TB – but must be strictly controlled to prevent further resistance.
Some have barely feasible healthcare ideas, others are in ‘populist’, ‘throwaway’ electioneering mode.